Abstract

INNOVATIONS AND ADVANCEMENTS IN REGULATORY AFFAIRS FOR THE EVOLUTION OF PHARMACEUTICAL SCIENCES AND DRUG DEVELOPMENT

Durga Boga*

ABSTRACT

This study examines the most recent developments and breakthroughs in regulatory affairs and how they affect drug development and the pharmaceutical sciences. By means of an all-inclusive approach that includes a review of relevant literature, interviews with experts, analysis of case studies, and trend analysis, the research pinpoints significant patterns evolving the regulatory environment. The results show how regulatory innovations are improving medication development procedures and market access. Examples of these innovations include the incorporation of artificial intelligence, adaptive clinical trials, and worldwide harmonization initiatives. The reportoutlines upcoming developments, such as digital transformation and personalized medicine, and tackles issues including data management and regulatory complexity. According to the study's findings, these developments will have a significant impact on how pharmaceutical sciences develop in the future, encourage innovation, and guarantee patient-centered outcomes.

Keywords: .